SK Bioscience Co (XKRX:302440) ROE % Adjusted to Book Value

: 0.30% (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

SK Bioscience Co's ROE % for the quarter that ended in Dec. 2023 was 0.97%. SK Bioscience Co's PB Ratio for the quarter that ended in Dec. 2023 was 3.25. SK Bioscience Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 0.30%.

SK Bioscience Co ROE % Adjusted to Book Value Historical Data

The historical data trend for SK Bioscience Co's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SK Bioscience Co Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

3.54

2.26

0.40

SK Bioscience Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															1.98	-1.03	-1.04	3.73	0.30

Competitive Comparison

For the Biotechnology subindustry, SK Bioscience Co's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SK Bioscience Co ROE % Adjusted to Book Value Distribution

For the Biotechnology industry and Healthcare sector, SK Bioscience Co's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where SK Bioscience Co's ROE % Adjusted to Book Value falls into.

SK Bioscience Co ROE % Adjusted to Book Value Calculation

SK Bioscience Co's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	1.30%	/	3.25
	=	0.40%

SK Bioscience Co's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	0.97%	/	3.25
	=	0.30%

SK Bioscience Co ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of SK Bioscience Co's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

SK Bioscience Co (XKRX:302440) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SK Bioscience Co Ltd (XKRX:302440) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

310, Pangyo-ro, Bundang-gu, Gyeonggi-do, Seongnam-si, KOR, 13494

Website

https://www.skbioscience.co.kr

SK Bioscience Co Ltd is a South Korean pharmaceutical company. It is engaged in the manufacturing and developing of vaccine. The company has registered SKYCellflu prefilled syringe (PFS), the first cell culture influenza vaccine in Korea, followed by the licensure of SKYCellflu Quadrivalent prefilled syringe and 13-valent Pneumococcal Conjugate Vaccine. Further it has several other vaccines under development and clinical trials including recombinant rotavirus vaccine. In addition, the development of new typhoid conjugate vaccine and innovative pneumococcal vaccine is ongoing in collaboration with external partners.

SK Bioscience Co (XKRX:302440) Headlines

No Headlines